A novel class of compounds, which act to antagonize the action of the
glucagon hormone on the glucagon receptor. Owing to their antagonizing
effect of the glucagon receptor the compounds may be suitable for the
treatment and/or prevention of any glucagon-mediated conditions and
diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and
obesity.